(Q33213984)

24 July 2017

1 reference

title

Sildenafil for pulmonary hypertension (English)

1 reference

24 July 2017

pulmonary hypertension

1 reference

Audrey J Lee

1

1 reference

24 July 2017

Teresa B Chiao

series ordinal

2

1 reference

24 July 2017

Mildred P Tsang

series ordinal

3

1 reference

24 July 2017

language of work or name

English

0 references

publication date

12 April 2005

1 reference

Annals of Pharmacotherapy

24 July 2017

1 reference

24 July 2017

39

1 reference

24 July 2017

869-884

1 reference

24 July 2017

5

1 reference

Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines

24 July 2017

1 reference

Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

21 January 2018

1 reference

Pulmonary hypertension: hemodynamic diagnosis and management

21 January 2018

1 reference

Advances in the treatment of secondary pulmonary hypertension

21 January 2018

1 reference

New treatments for pulmonary arterial hypertension

21 January 2018

1 reference

Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: A review

21 January 2018

1 reference

Treatment of rebound and chronic pulmonary hypertension with oral sildenafil in an infant with congenital diaphragmatic hernia

21 January 2018

1 reference

Treatment of primary pulmonary hypertension with oral sildenafil

21 January 2018

1 reference

Sildenafil ameliorates effects of inhaled nitric oxide withdrawal

21 January 2018

1 reference

Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery

21 January 2018

1 reference

Non erectile dysfunction application of sildenafil

21 January 2018

1 reference

Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide

21 January 2018

1 reference

Psychophysical bases of perceived exertion

21 January 2018

1 reference

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

21 January 2018

1 reference

Current management of primary pulmonary hypertension

21 January 2018

1 reference

Bosentan for the treatment of pulmonary arterial hypertension

21 January 2018

1 reference

Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease.

21 January 2018

1 reference

Inhaled iloprost: in primary pulmonary hypertension

21 January 2018

1 reference

Inhaled iloprost for severe pulmonary hypertension

21 January 2018

1 reference

Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

21 January 2018

1 reference

Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin

21 January 2018

1 reference

Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

21 January 2018

1 reference

High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.

21 January 2018

1 reference

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

Coronary and systemic hemodynamic effects of sildenafil citrate: from basic science to clinical studies in patients with cardiovascular disease

21 January 2018

1 reference

Sildenafil inhibits hypoxia-induced pulmonary hypertension

21 January 2018

1 reference

Sildenafil in secondary pulmonary hypertension.

21 January 2018

1 reference

Sildenafil treatment of primary pulmonary hypertension

21 January 2018

1 reference

Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension

21 January 2018

1 reference

Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

21 January 2018

1 reference

Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension

21 January 2018

1 reference

Acute effects of sildenafil in patients with primary pulmonary hypertension receiving epoprostenol

21 January 2018

1 reference

Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension

21 January 2018

1 reference

Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

21 January 2018

1 reference

Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study

21 January 2018

1 reference

Early haemodynamic benefit of sildenafil in patients with coexisting chronic thromboembolic pulmonary hypertension and left ventricular dysfunction

21 January 2018

1 reference

Efficacy and optimal dose of sildenafil in primary pulmonary hypertension

21 January 2018

1 reference

Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects

21 January 2018

1 reference

Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension

21 January 2018

1 reference

Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial Hypertension

21 January 2018

1 reference

Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension

21 January 2018

1 reference

Immediate and Long-term Hemodynamic and Clinical Effects of Sildenafil in Patients With Pulmonary Arterial Hypertension Receiving Vasodilator Therapy

21 January 2018

1 reference

Viagra (sildenafil citrate) and ophthalmology

21 January 2018

1 reference

Severe retinopathy of prematurity (ROP) in a premature baby treated with sildenafil acetate (Viagra) for pulmonary hypertension

21 January 2018

1 reference

Nonarteritic ischemic optic neuropathy developing soon after use of sildenafil (viagra): a report of seven new cases

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1E426

1 reference

24 July 2017

1 reference